je.st
news
Tag: meeting
Eisai to Present New Research on Oncology Products and Pipeline at 50th Asco Annual Meeting
2014-05-15 07:54:39| Logistics - Topix.net
Highlights Include New Phase Iii Clinical Data on Investigational Anticancer Agent Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer Tokyo, May 15, 2014 - - Eisai Co., Ltd. announced today that a series of abstracts highlighting new study results on Halaven and lenvatinib with a novel binding mode) will be presented during the 50th ... (more)
Tags: products
research
present
meeting
UPDATE 1-Bristol, Merck, Roche immune therapies are cancer meeting focus
2014-05-15 03:35:01| Biotech - Topix.net
When the world's leading cancer doctors meet in Chicago next month, new treatments from Merck & Co, Bristol-Myers Squibb Co and Roche Holding AG that help the immune system fight disease are expected to capture much of the spotlight.
Tags: update
focus
meeting
cancer
Find Meeting and Board Contact Info
2014-05-15 01:46:25| PortlandOnline
Neighborhood Association meeting and contact information.
Mercks Investigational Anti-PD1 Antibody, MK-3475, Active in Three Different Tumor Types: New Data to be Presented at the 2014 ASCO Annual Meeting
2014-05-14 14:00:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. Six oral presentations report MK-3475 monotherapy data across three different tumor types and multiple lines of therapy Late-breaker presentation of long-term findings of MK-3475 in advanced melanoma, including ipilimumab-nave and treated settings; data included in ASCO Press Program First presentation of findings evaluating MK-3475 as initial treatment of patients with advanced non-small cell lung cancer First presentation of findings of MK-3475 in recurrent/metastatic head and neck cancer WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that new data for the companys investigational anti-PD-1 antibody, MK-3475, in advanced melanoma, non-small cell lung cancer (NSCLC), and head and neck cancer, are scheduled to be presented at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago on May 30 June 3, 2014. Language: English Contact: MerckMedia:Ian McConnell, 908-423-3046orClaire Mulhearn, 908-423-7425orInvestors:Carol Ferguson, 908-423-4465orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Portland Children's Levy Meeting
2014-05-13 18:37:11| PortlandOnline
Recorded 05-12-14
Tags: meeting
portland
levy
childrens
Sites : [804] [805] [806] [807] [808] [809] [810] [811] [812] [813] [814] [815] [816] [817] [818] [819] [820] [821] [822] [823] next »